BNP Paribas Financial Markets
PPBT

BNP Paribas Financial Markets’s Purple Biotech PPBT Stock Holding History

BNP Paribas Financial Markets’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,957
Closed -$7.91K – 6099
2026
Q1 		$7.91K Sell
1,957
-151
-7% -$815 ﹤0.01% 5256
2025
Q4 		$13.9K Buy
2,108
+980
+87% +$7.11K ﹤0.01% 5103
2025
Q3 		$6.47K Buy
1,128
+500
+80% +$8.97K ﹤0.01% 5070
2025
Q2 		$14.7K Buy
628
+90
+17% +$2.23K ﹤0.01% 4727
2025
Q1 		$14.3K Hold
538
– – ﹤0.01% 4625
2024
Q4 		$25.2K Buy
538
+170
+46% +$6.54K ﹤0.01% 4662
2024
Q3 		$20.4K Buy
+368
New +$27.8K ﹤0.01% 3745

Other funds holding PPBT

SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

BNP Paribas Financial Markets's PPBT Position: Q2 2026 in Review

BNP Paribas Financial Markets sold out of Purple Biotech (PPBT) in Q2 2026, closing a stake of 1,957 shares — an estimated $7.91K sold.

BNP Paribas Financial Markets first reported a position in PPBT in Q3 2024 and held it in 7 quarters. The position peaked at $25.2K in Q4 2024. 13 funds tracked by Wall St. Rank hold PPBT as of Q2 2026.

  • BNP Paribas Financial Markets reported no remaining Purple Biotech position as of Q2 2026 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1,957 Purple Biotech shares in Q2 2026, an estimated $7.91K.
  • BNP Paribas Financial Markets first reported a position in Purple Biotech in Q3 2024 and held it in 7 quarters.
  • BNP Paribas Financial Markets's Purple Biotech position peaked at $25.2K in Q4 2024.
  • 13 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.